Skip to main content
SpringerLink
Log in

Tips to start an MR-US fusion biopsy program

  • Special section: Prostate cancer update
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

There is growing evidence that MRI-ultrasound (MR-US)-targeted biopsy (TB) has high detection rates of clinically significant prostate cancer (PCa) compared to standard transrectal ultrasound (TRUS)-guided biopsy. A radiologist plays a significant role in MR-US fusion biopsy planning. Here, we discuss six simple steps that can help set up a successful MR-US fusion biopsy program in collaboration with the urologist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kim SP, Karnes RJ, Mwangi R, Van Houten H, Gross CP, Gershman B, Leapman MS, Shah ND. Contemporary Trends in Magnetic Resonance Imaging at the Time of Prostate Biopsy: Results from a Large Private Insurance Database. Eur Urol Focus 2019. https://doi.org/10.1016/j.euf.2019.03.016

  2. Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM, Thoeny HC, Verma S. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69(1):16-40. https://doi.org/10.1016/j.eururo.2015.08.052

  3. Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 2015;313(4):390-397. https://doi.org/10.1001/jama.2014.17942

  4. Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, Briganti A, Budaus L, Hellawell G, Hindley RG, Roobol MJ, Eggener S, Ghei M, Villers A, Bladou F, Villeirs GM, Virdi J, Boxler S, Robert G, Singh PB, Venderink W, Hadaschik BA, Ruffion A, Hu JC, Margolis D, Crouzet S, Klotz L, Taneja SS, Pinto P, Gill I, Allen C, Giganti F, Freeman A, Morris S, Punwani S, Williams NR, Brew-Graves C, Deeks J, Takwoingi Y, Emberton M, Moore CM, Collaborators PSG. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med 2018;378(19):1767-1777. https://doi.org/10.1056/nejmoa1801993

  5. Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. J Urol 2016;196(6):1613-1618. https://doi.org/10.1016/j.juro.2016.06.079

  6. NCCN Guidelines Version 2.2018: Prostate Cancer Early Detection.

  7. NCCN Guidelines Version 2.2019: Prostate Cancer Early Detection.

  8. Verma S, Choyke PL, Eberhardt SC, Oto A, Tempany CM, Turkbey B, Rosenkrantz AB. The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer. Radiology 2017;285(2):343-356. https://doi.org/10.1148/radiol.2017161684

  9. Wegelin O, Exterkate L, van der Leest M, Kummer JA, Vreuls W, de Bruin PC, Bosch J, Barentsz JO, Somford DM, van Melick HHE. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies. Eur Urol 2019;75(4):582-590. https://doi.org/10.1016/j.eururo.2018.11.040

  10. Sadhna Verma, Peter L. Choyke, Steven C. Eberhardt, Aytekin Oto, Clare M. Tempany, Baris Turkbey, Andrew B. Rosenkrantz: The Current State of MR Imaging–targeted Biopsy Techniques for Detection of Prostate Cancer, Radiology 2017; Nov;285(2):343-356. https://doi.org/10.1148/radiol.2017161684

  11. Rosenkrantz AB, Ginocchio LA, Cornfeld D, et al. Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists. Radiology. 2016 Sep;280(3):793–804.

  12. Patel NU, Lind KE, Garg K, Crawford D, Werahera PN, Pokharel SS. Assessment of PI-RADS v2 categories ≥ 3 for diagnosis of clinically significant prostate cancer. Abdom Radiol (NY). 2019 Feb;44(2):705-712. https://doi.org/10.1007/s00261-018-1751-5.

  13. Natarajan S, Marks LS, Margolis DJ, Huang J, Macairan ML, Lieu P, Fenster A. Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol 2011;29(3):334-342. https://doi.org/10.1016/j.urolonc.2011.02.014

  14. Xu S, Kruecker J, Turkbey B, Glossop N, Singh AK, Choyke P, Pinto P, Wood BJ. Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies. Comput Aided Surg 2008;13(5):255-264. https://doi.org/10.3109/10929080802364645

  15. Martin PR, Cool DW, Romagnoli C, Fenster A, Ward AD. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis. Med Phys 2014;41(7):073504. https://doi.org/10.1118/1.4883838

  16. Kuru TH, Roethke MC, Seidenader J, Simpfendorfer T, Boxler S, Alammar K, Rieker P, Popeneciu VI, Roth W, Pahernik S, Schlemmer HP, Hohenfellner M, Hadaschik BA. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. J Urol 2013;190(4):1380-1386. https://doi.org/10.1016/j.juro.2013.04.043

  17. Sonn GA, Natarajan S, Margolis DJ, MacAiran M, Lieu P, Huang J, Dorey FJ, Marks LS. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol 2013;189(1):86-91. https://doi.org/10.1016/j.juro.2012.08.095

  18. Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol 2014;65(4):809-815. https://doi.org/10.1016/j.eururo.2013.03.025

  19. Schimmoller L, Quentin M, Blondin D, Dietzel F, Hiester A, Schleich C, Thomas C, Rabenalt R, Gabbert HE, Albers P, Antoch G, Arsov C. Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required? Eur Radiol 2016;26(11):3858-3864. https://doi.org/10.1007/s00330-016-4266-x

  20. Zhang M, Milot L, Khalvati F, Sugar L, Downes M, Baig SM, Klotz L, Haider MA. Value of Increasing Biopsy Cores per Target with Cognitive MRI-targeted Transrectal US Prostate Biopsy. Radiology 2019;291(1):83-89. https://doi.org/10.1148/radiol.2019180712

  21. Salami SS, Ben-Levi E, Yaskiv O, Ryniker L, Turkbey B, Kavoussi LR, Villani R, Rastinehad AR. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int 2015;115(4):562-570. https://doi.org/10.1111/bju.12938

  22. Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E, Gabbert HE, Becker N, Antoch G, Albers P, Schimmoller L. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol 2015;68(4):713-720. https://doi.org/10.1016/j.eururo.2015.06.008

  23. Kasabwala K, Patel N, Cricco-Lizza E, Shimpi AA, Weng S, Buchmann RM, Motanagh S, Wu Y, Banerjee S, Khani F, Margolis DJ, Robinson BD, Hu JC. The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy. Eur Urol Oncol. 2019 Mar;2(2):135-140. https://doi.org/10.1016/j.euo.2018.07.005. Epub 2018 Aug 17.

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University of Colorado Anschutz Medical Campus, Aurora, USA

    Alison Sheridan

  2. Division of Urology, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, USA

    Paul Maroni

  3. Department of Radiology, University of Colorado Anschutz Medical Campus, 12401 E. 17th Avenue, MS L954, Room 5-005, Aurora, CO, 80045, USA

    Nayana U. Patel

Authors
  1. Alison Sheridan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Maroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nayana U. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nayana U. Patel.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sheridan, A., Maroni, P. & Patel, N.U. Tips to start an MR-US fusion biopsy program. Abdom Radiol 45, 4023–4027 (2020). https://doi.org/10.1007/s00261-020-02606-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02606-3

Keywords

Search

Navigation